Inclined to agree with $2 as a solid base. Technical analysis is a nice tool , but fails to account for the fundamental fact that Roche has entered the picture. Added some more at 2.18.
Like to see gap up on Mon. Need to sell my pos 2.50 and 2.34 before this drop again. In my dreamworld, I'd like to sell at 2.60-2.70 .. not going to be greedy. I don't see $3 coming anytime soon unless another partnership or data release (which would be next year).